Efficacy of donepezil on secondary end points in a randomized, double-blind placebo-controlled study in severe Alzheimer's disease

被引：0
|
作者：
Eriksson, S
Winblad, B
Kilander, L
Batsman, S
Jansson-Blixt, C
Wetterholm, AL
Haglund, A
Minthon, L
机构：
[1] Umea Univ, Umea, Sweden
[2] Karolinska Inst, Stockholm, Sweden
[3] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden
[4] Kalix Vardcent, Dept Primary Care, Kalix, Sweden
[5] Pfizer Biostat, Taby, Sweden
[6] Pfizer Neurosci, Taby, Sweden
[7] Univ Hosp MAS, Neuropsychiat Clin, Malmo, Sweden
来源：
INTERNATIONAL PSYCHOGERIATRICS | 2005年 / 17卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [1] Efficacy of donepezil on secondary end points in a randomized, double-blind, placebo-controlled study in severe Alzheimer's disease
    Winblad, B
    Eriksson, S
    Kilander, L
    Båtsman, S
    Jansson-Blix, C
    Wetterholm, AL
    Haglund, A
    Minthon, L
    NEUROLOGY, 2006, 66 (05) : A350 - A350
  • [2] Efficacy of donepezil on primary end points in a randomized, double-blind placebo-controlled study in severe Alzheimer's disease
    Winblad, B
    Minthon, L
    Eriksson, S
    Batsman, S
    Jansson-Blixt, C
    Wetterholm, AL
    Haglund, A
    Kilander, L
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 238 - 239
  • [3] A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting
    Tariot, PN
    Cummings, JL
    Katz, IR
    Mintzer, J
    Perdomo, CA
    Schwam, EM
    Whalen, E
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (12) : 1590 - 1599
  • [4] Donepezil in patients with severe Alzheimer's disease:: double-blind, parallel-group, placebo-controlled study
    Winblad, B
    Kilander, L
    Eriksson, S
    Minthon, L
    Båtsman, S
    Wetterholm, AL
    Jarisson-Blixt, C
    Hoglund, A
    LANCET, 2006, 367 (9516): : 1057 - 1065
  • [5] Donepezil improves sleep apnea in Alzheimer's disease: A double-blind placebo-controlled study
    Moraes, W.
    Poyares, D.
    Sukys-Claudino, L.
    Guilleminault, C.
    Tufik, S.
    SLEEP, 2007, 30 : A304 - A304
  • [6] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer's Disease
    Yokoyama, Shunichi
    Yoshinaga, Takuma
    Matsuzaki, Juntaro
    Suzuki, Hidekazu
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (04) : 1187 - 1199
  • [7] The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial
    Rogers, SL
    Friedhoff, LT
    Apter, JT
    Richter, RW
    Hartford, JT
    Walshe, TM
    Baumel, B
    Linden, RD
    Kinney, FC
    Doody, RS
    Borison, RL
    Ahem, GL
    DEMENTIA, 1996, 7 (06): : 293 - 303
  • [8] DHEA treatment of Alzheimer's disease - A randomized, double-blind, placebo-controlled study
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Costa, MM
    Yaffe, K
    Walton, P
    Raskind, M
    Peskind, E
    Newhouse, P
    Sack, D
    De Souza, E
    Sadowsky, C
    Roberts, E
    NEUROLOGY, 2003, 60 (07) : 1071 - 1076
  • [9] Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study
    Mazza, M.
    Capuano, A.
    Bria, P.
    Mazza, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (09) : 981 - 985
  • [10] Donepezil for dementia in Parkinson's disease: A randomized, double-blind, placebo-controlled, crossover study.
    Ravina, B
    Putt, M
    Siderowf, A
    Farrar, JT
    Gillespie, M
    Crawley, A
    Fernandez, H
    Treischmann, M
    Reichwein, S
    Simuni, T
    MOVEMENT DISORDERS, 2004, 19 (09) : 1132 - 1133
12345